NVDA: Options Hedging Eases but the Stock Can't Find Its Footing

NVIDIA closes out the week at $216.47, down 5.3% over five sessions, and the picture is one of a stock still stuck in repair mode rather than one finding a floor.

The modest improvement in options positioning is the clearest shift from last week's note. The put/call ratio has pulled back to 1.02 from a mid-week peak of 1.22 on October 15, the highest reading of the past year. The 20-day average sits at 0.97, and the z-score of 0.50 puts the current reading in relatively normal territory. That is a meaningful easing from where things stood on Tuesday, but the PCR has now spent most of the past two weeks above 1.0, a level that was rare through September. Options traders are less alarmed than they were mid-week, but they haven't gone back to the relaxed posture of a month ago. The borrow market offers no conflicting signal. Shares are extremely easy to source, with availability far exceeding what short sellers need, and cost to borrow has more than halved on the week to just 0.11%, its lowest level in six weeks. Short interest itself remains a secondary story: at 1.29% of free float, it has crept up roughly 7% over the past month, but the absolute level is too low to generate meaningful squeeze dynamics. The steady drift higher in SI is worth tracking, not alarming.

The Street has not materially shifted its view. Analyst data is approximately two weeks stale, but the most recent actions through early October show universal buy-side conviction: targets cluster between $300 and $400, with Bernstein at $400 and Rosenblatt at $390 sitting at the high end, against a mean of $329. At $216, that implies roughly 52% upside to the consensus target, a gap that has widened as the stock has given back ground since its early October peak near $239. The bull case centres on AI infrastructure demand running well ahead of supply constraints, with management citing 70%-plus revenue growth for 2027 and the Rubin architecture delivering meaningfully higher revenue per gigawatt than its predecessors. Bears point to the cyclicality embedded in that growth, China export controls, and the risk that hyperscaler capex commitments slow faster than the order book implies. The trailing PE has compressed to around 14.8 and the EV/EBITDA ratio to 12.3, both down materially over the past 30 days as the price has pulled back without a corresponding earnings revision. ORTEX factor scores show EPS momentum remains solid, ranking in the 76th percentile on a 30-day basis and the 81st on 90 days, suggesting the earnings revision cycle hasn't turned negative.

The one piece of colour from the attention data is worth flagging. Wikipedia views, tracked by the Wikimedia Foundation, show retail attention to NVIDIA running at its lowest level relative to the stock's own 90-day history, with a z-score of minus 3.1 as of October 5. This dataset has not been measured to lead the company's reported figures, so it carries no forecasting weight. It does suggest that the retail enthusiasm that surrounded the stock through much of 2025 has faded materially, consistent with the price action.

Insider activity over the past 90 days tells a net-selling story, though much of it comes through pre-arranged 10b5-1 plans. CFO Colette Kress sold roughly $7.6 million in mid-September under a plan. Director Mark Stevens sold approximately $300 million on September 18 outside of any plan, which is the one notable discretionary move in the data. CEO Jensen Huang transferred 438,000 shares on September 17, a gifting transaction rather than an open-market sale. Net of all transactions, insiders disposed of roughly 4.3 million shares worth just under $968 million over the 90-day window. The Stevens sale stands out for its size and its discretionary nature, but a single director trade against a $5.2 trillion market cap moves the needle less than it might for a smaller name.

Semiconductor peers had a rough week broadly. AMD fell 11.7% over five days, SITM dropped 14.2%, and HIMX lost 6.5%. NVIDIA's 5.3% decline looks relatively contained by comparison, though at this market cap even contained declines represent substantial value erosion. The November 25 earnings call is 35 days away, and the question heading into that print is whether the gap between the current price and Street targets reflects genuine fundamental risk or simply a market rotation that has left the chip sector behind.